A Study to Evaluate Pharmacokinetic (PK), Safety and Tolerability of GSK2894512 in Healthy Adult Subjects

NCT03201978 · clinicaltrials.gov ↗
PHASE1
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class

Stopped The whole project was discontinued within GSK, hence this study was cancelled before enrolment.

Conditions

Interventions

Sponsor

GlaxoSmithKline

Collaborators